Evaluation of AI-Based Segmentation Tools for COVID-19 Lung Lesions on Conventional and Ultra-low Dose CT Scans

A reliable diagnosis and accurate monitoring are pivotal steps for treatment and prevention of COVID-19. Chest computed tomography (CT) has been considered a crucial diagnostic imaging technique for the injury assessment of the viral pneumonia. Furthermore, the automatization of the segmentation met...

Full description

Bibliographic Details
Main Authors: Marco Aiello, Dario Baldi, Giuseppina Esposito, Marika Valentino, Marco Randon, Marco Salvatore, Carlo Cavaliere
Format: Article
Language:English
Published: SAGE Publishing 2022-04-01
Series:Dose-Response
Online Access:https://doi.org/10.1177/15593258221082896
_version_ 1818475040831700992
author Marco Aiello
Dario Baldi
Giuseppina Esposito
Marika Valentino
Marco Randon
Marco Salvatore
Carlo Cavaliere
author_facet Marco Aiello
Dario Baldi
Giuseppina Esposito
Marika Valentino
Marco Randon
Marco Salvatore
Carlo Cavaliere
author_sort Marco Aiello
collection DOAJ
description A reliable diagnosis and accurate monitoring are pivotal steps for treatment and prevention of COVID-19. Chest computed tomography (CT) has been considered a crucial diagnostic imaging technique for the injury assessment of the viral pneumonia. Furthermore, the automatization of the segmentation methods for lung alterations helps to speed up the diagnosis and lighten radiologists’ workload. Considering the assiduous pathology monitoring, ultra-low dose (ULD) chest CT protocols have been implemented to drastically reduce the radiation burden. Unfortunately, the available AI technologies have not been trained on ULD-CT data and validated and their applicability deserves careful evaluation. Therefore, this work aims to compare the results of available AI tools (BCUnet, CORADS AI, NVIDIA CLARA Train SDK and CT Pneumonia Analysis) on a dataset of 73 CT examinations acquired both with conventional dose (CD) and ULD protocols. COVID-19 volume percentage, resulting from each tool, was statistically compared. This study demonstrated high comparability of the results on CD-CT and ULD-CT data among the four AI tools, with high correlation between the results obtained on both protocols (R > .68, P < .001, for all AI tools).
first_indexed 2024-04-14T04:45:18Z
format Article
id doaj.art-3056a8461a59484d8f7c499635e0e789
institution Directory Open Access Journal
issn 1559-3258
language English
last_indexed 2024-04-14T04:45:18Z
publishDate 2022-04-01
publisher SAGE Publishing
record_format Article
series Dose-Response
spelling doaj.art-3056a8461a59484d8f7c499635e0e7892022-12-22T02:11:29ZengSAGE PublishingDose-Response1559-32582022-04-012010.1177/15593258221082896Evaluation of AI-Based Segmentation Tools for COVID-19 Lung Lesions on Conventional and Ultra-low Dose CT ScansMarco AielloDario BaldiGiuseppina EspositoMarika ValentinoMarco RandonMarco SalvatoreCarlo CavaliereA reliable diagnosis and accurate monitoring are pivotal steps for treatment and prevention of COVID-19. Chest computed tomography (CT) has been considered a crucial diagnostic imaging technique for the injury assessment of the viral pneumonia. Furthermore, the automatization of the segmentation methods for lung alterations helps to speed up the diagnosis and lighten radiologists’ workload. Considering the assiduous pathology monitoring, ultra-low dose (ULD) chest CT protocols have been implemented to drastically reduce the radiation burden. Unfortunately, the available AI technologies have not been trained on ULD-CT data and validated and their applicability deserves careful evaluation. Therefore, this work aims to compare the results of available AI tools (BCUnet, CORADS AI, NVIDIA CLARA Train SDK and CT Pneumonia Analysis) on a dataset of 73 CT examinations acquired both with conventional dose (CD) and ULD protocols. COVID-19 volume percentage, resulting from each tool, was statistically compared. This study demonstrated high comparability of the results on CD-CT and ULD-CT data among the four AI tools, with high correlation between the results obtained on both protocols (R > .68, P < .001, for all AI tools).https://doi.org/10.1177/15593258221082896
spellingShingle Marco Aiello
Dario Baldi
Giuseppina Esposito
Marika Valentino
Marco Randon
Marco Salvatore
Carlo Cavaliere
Evaluation of AI-Based Segmentation Tools for COVID-19 Lung Lesions on Conventional and Ultra-low Dose CT Scans
Dose-Response
title Evaluation of AI-Based Segmentation Tools for COVID-19 Lung Lesions on Conventional and Ultra-low Dose CT Scans
title_full Evaluation of AI-Based Segmentation Tools for COVID-19 Lung Lesions on Conventional and Ultra-low Dose CT Scans
title_fullStr Evaluation of AI-Based Segmentation Tools for COVID-19 Lung Lesions on Conventional and Ultra-low Dose CT Scans
title_full_unstemmed Evaluation of AI-Based Segmentation Tools for COVID-19 Lung Lesions on Conventional and Ultra-low Dose CT Scans
title_short Evaluation of AI-Based Segmentation Tools for COVID-19 Lung Lesions on Conventional and Ultra-low Dose CT Scans
title_sort evaluation of ai based segmentation tools for covid 19 lung lesions on conventional and ultra low dose ct scans
url https://doi.org/10.1177/15593258221082896
work_keys_str_mv AT marcoaiello evaluationofaibasedsegmentationtoolsforcovid19lunglesionsonconventionalandultralowdosectscans
AT dariobaldi evaluationofaibasedsegmentationtoolsforcovid19lunglesionsonconventionalandultralowdosectscans
AT giuseppinaesposito evaluationofaibasedsegmentationtoolsforcovid19lunglesionsonconventionalandultralowdosectscans
AT marikavalentino evaluationofaibasedsegmentationtoolsforcovid19lunglesionsonconventionalandultralowdosectscans
AT marcorandon evaluationofaibasedsegmentationtoolsforcovid19lunglesionsonconventionalandultralowdosectscans
AT marcosalvatore evaluationofaibasedsegmentationtoolsforcovid19lunglesionsonconventionalandultralowdosectscans
AT carlocavaliere evaluationofaibasedsegmentationtoolsforcovid19lunglesionsonconventionalandultralowdosectscans